Devon Park BioVentures
18
26M
10
1.12
2
0.44
4
- Stages of investment
- Areas of investment
Summary
Devon Park BioVentures is the famous VC, which was founded in 2006. The company was established in North America in United States. The main department of described VC is located in the Wayne.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ZS Pharma, Diasome, MicuRx Pharmaceuticals. Among the most successful fund investment fields, there are Biotechnology, Nanotechnology. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
Besides them, we counted 2 critical employees of this fund in our database.
The top amount of exits for fund were in 2014. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2012. Opposing the other organizations, this Devon Park BioVentures works on 4 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Devon Park BioVentures, startups are often financed by Intersouth Partners, TVM Capital, Prism Venture Management. The meaningful sponsors for the fund in investment in the same round are Intersouth Partners, TVM Capital, Skyline Ventures. In the next rounds fund is usually obtained by TVM Capital, Prism Venture Management, Intersouth Partners.
Investments analytics
Analytics
- Total investments
- 18
- Lead investments
- 2
- Exits
- 4
- Rounds per year
- 1.12
- Follow on index
- 0.44
- Investments by industry
- Biotechnology (16)
- Health Care (9)
- Medical (9)
- Pharmaceutical (9)
- Health Diagnostics (4) Show 5 more
- Investments by region
-
- United States (16)
- Peak activity year
- 2012
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 830K
- Group Appearance index
- 0.94
- Avg. company exit year
- 21
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Proteon Therapeutics | 12 Aug 2011 | Biotechnology, Medical, Pharmaceutical | Late Stage Venture | 15M | United States, Massachusetts |
Vascular Magnetics | 22 Feb 2012 | Biotechnology, Health Care, Medical Device, Medical, Nanotechnology | Early Stage Venture | 7M | United States, Pennsylvania, Philadelphia |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.